CA1337177C - Bioparyl, a biological regulator, active against various pathologies - Google Patents
Bioparyl, a biological regulator, active against various pathologiesInfo
- Publication number
- CA1337177C CA1337177C CA000603639A CA603639A CA1337177C CA 1337177 C CA1337177 C CA 1337177C CA 000603639 A CA000603639 A CA 000603639A CA 603639 A CA603639 A CA 603639A CA 1337177 C CA1337177 C CA 1337177C
- Authority
- CA
- Canada
- Prior art keywords
- bioparyl
- mammal
- fibrosis
- activity
- globulins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000007170 pathology Effects 0.000 title 1
- 102000006382 Ribonucleases Human genes 0.000 claims abstract 8
- 108010083644 Ribonucleases Proteins 0.000 claims abstract 8
- 230000000694 effects Effects 0.000 claims abstract 6
- 206010016654 Fibrosis Diseases 0.000 claims abstract 5
- 230000004761 fibrosis Effects 0.000 claims abstract 5
- 206010028980 Neoplasm Diseases 0.000 claims abstract 4
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract 3
- 241001465754 Metazoa Species 0.000 claims abstract 3
- 108010074605 gamma-Globulins Proteins 0.000 claims abstract 3
- 102000018358 immunoglobulin Human genes 0.000 claims abstract 3
- 229940072221 immunoglobulins Drugs 0.000 claims abstract 3
- 230000005855 radiation Effects 0.000 claims abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract 2
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 210000004072 lung Anatomy 0.000 claims abstract 2
- 241000124008 Mammalia Species 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 3
- 230000018109 developmental process Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000006228 supernatant Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010050207 Skin fibrosis Diseases 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000011712 cell development Effects 0.000 claims 1
- 238000004440 column chromatography Methods 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8809738A FR2634380B1 (fr) | 1988-07-19 | 1988-07-19 | Regulateur biologique, actif dans diverses pathologies |
| FR8809738 | 1988-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1337177C true CA1337177C (en) | 1995-10-03 |
Family
ID=9368543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000603639A Expired - Fee Related CA1337177C (en) | 1988-07-19 | 1989-06-22 | Bioparyl, a biological regulator, active against various pathologies |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0352146B1 (h) |
| JP (1) | JPH0278628A (h) |
| CA (1) | CA1337177C (h) |
| DE (1) | DE68903065T2 (h) |
| DK (1) | DK355089A (h) |
| ES (1) | ES2052942T3 (h) |
| FR (1) | FR2634380B1 (h) |
| GR (1) | GR3006687T3 (h) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3832056A1 (de) * | 1988-09-21 | 1990-03-22 | Scholle Helmut Dr Med | Verwendung eines ginkgo-extraktes |
| DE4030758A1 (de) * | 1990-09-28 | 1992-04-02 | Schwabe Willmar Gmbh & Co | Extrakt aus blaettern von ginkgo biloba, insbesondere zur intravenoesen injektion oder infusion, verfahren zu seiner herstellung und den extrakt enthaltende ampullenpraeparate |
| DE4308443C2 (de) * | 1993-03-17 | 1996-09-19 | Laves Hans Georg | Arzneimittel zur Behandlung von Retrovirusinfektionen |
| FR2754714B1 (fr) * | 1996-10-22 | 1999-01-22 | Roc Sa | Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba |
| FR2759371B1 (fr) * | 1997-02-07 | 1999-03-19 | Bio Merieux | Utilisation d'un polypeptide, pour obtenir une composition pour detecter, prevenir ou traiter une maladie degenerative et/ou auto-immune |
| US6030621A (en) * | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
| WO2002011745A1 (en) * | 2000-08-04 | 2002-02-14 | Angiolab, Inc. | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
| KR100417172B1 (ko) * | 2000-08-04 | 2004-02-05 | 주식회사 안지오랩 | 은행엽 엑스를 유효성분으로 하는 혈관신생 억제제 |
| FR2911782A1 (fr) * | 2007-01-31 | 2008-08-01 | Jacqueline Martin | Comment guerir du sida avec mentha pulegium et ginkgo biloba |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2117429C3 (de) * | 1971-04-08 | 1982-04-01 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Verfahren zur Herstellung eines Injektions- bzw. Infusionspräparates mit einem Gehalt an einem Wirkstoffgemisch aus den Blättern von Ginkgo biloba |
| FR2518406A1 (fr) * | 1981-12-22 | 1983-06-24 | Prodipharm | Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo |
-
1988
- 1988-07-19 FR FR8809738A patent/FR2634380B1/fr not_active Expired - Lifetime
-
1989
- 1989-04-26 ES ES89401191T patent/ES2052942T3/es not_active Expired - Lifetime
- 1989-04-26 EP EP89401191A patent/EP0352146B1/fr not_active Expired - Lifetime
- 1989-04-26 DE DE8989401191T patent/DE68903065T2/de not_active Expired - Fee Related
- 1989-06-22 CA CA000603639A patent/CA1337177C/en not_active Expired - Fee Related
- 1989-07-18 DK DK355089A patent/DK355089A/da not_active Application Discontinuation
- 1989-07-19 JP JP1184843A patent/JPH0278628A/ja active Pending
-
1992
- 1992-12-28 GR GR920403150T patent/GR3006687T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0352146A1 (fr) | 1990-01-24 |
| DE68903065D1 (de) | 1992-11-05 |
| JPH0278628A (ja) | 1990-03-19 |
| FR2634380B1 (fr) | 1990-10-12 |
| ES2052942T3 (es) | 1994-07-16 |
| GR3006687T3 (h) | 1993-06-30 |
| DE68903065T2 (de) | 1993-03-25 |
| DK355089D0 (da) | 1989-07-18 |
| FR2634380A1 (fr) | 1990-01-26 |
| DK355089A (da) | 1990-01-20 |
| EP0352146B1 (fr) | 1992-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schwartz et al. | Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression | |
| EP0348353B1 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
| US4762705A (en) | Cancer therapy with interferon | |
| US5145839A (en) | Pharmaceutical composition and method of use | |
| EP0113162B1 (en) | Anti-proliferative action of dsnras on tumor cells | |
| CA1337177C (en) | Bioparyl, a biological regulator, active against various pathologies | |
| Rao et al. | Preliminary investigation of the radiosensitizing activity of guduchi (Tinospora cordifolia) in tumor‐bearing mice | |
| CN116286391A (zh) | 链格孢菌的发酵化合物在治疗炎性损伤类疾病中的应用 | |
| Ito et al. | Effect of human leukocyte interferon on the metastatic lung tumor of osteosarcoma. Case reports | |
| KR20160122094A (ko) | 알러지 유발 물질을 저감시킨 정제 봉독을 유효성분으로 함유하는 염증성 질환 예방 및 치료용 약학적 조성물 | |
| US5413787A (en) | Bioparyl, a biological regulator, active against various pathologies | |
| US5151425A (en) | Method of and composition for treating inflammation and the immunological response thereto | |
| US11371037B1 (en) | Zinc-charged pancreatic enzymes for treatment of cancer and inflammation | |
| JP2003504410A (ja) | 藻類のプロテオグリカン抽出物およびその使用方法 | |
| US7589062B2 (en) | Two synthetic peptides for treatment and prevention of cancers | |
| IL91428A (en) | Bioparyl a biological regulator active against various pathologies | |
| CA2378726A1 (en) | Compositions containing muscle-derived active agents | |
| CN112618569A (zh) | 一种用于治疗尿路上皮癌的药物 | |
| WO2021185292A1 (zh) | 黄耆医药组合物在用于制备增强癌症治疗药物中的用途 | |
| US20050272654A1 (en) | NF-kappaB activation inhibitors, and their pharmaceutical uses | |
| EA002290B1 (ru) | Противоопухолевое средство | |
| US6312737B1 (en) | Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou | |
| Popov et al. | The antimetastatic and immunomodulating activities of ginseng minor glycosides. | |
| US5939072A (en) | Herbal composition and method of treating viral infection of the liver | |
| US5929104A (en) | Method for inducing apoptosis of cancer cell |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |